報價延遲最少15分鐘:2025/02/01 12:03 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
6.2 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.66/--
|
|
企業價值
216.45M
|
| 資產負債 |
|
每股賬面淨值
0.09
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
2.73M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/02/01 12:03 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV),was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis - a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. |